InvestorsHub Logo
Post# of 84262
Next 10
Followers 70
Posts 2498
Boards Moderated 0
Alias Born 08/11/2017

Re: None

Thursday, 01/27/2022 1:25:06 PM

Thursday, January 27, 2022 1:25:06 PM

Post# of 84262
$MSSV GSCG $2.5M cash, low float, paid former LAH* share holders a first in the OTC.

https://www.stemcellsgroup.com/


https://www.otcmarkets.com/stock/MSSV/security



warrant maturity has been changed to 7 years instead of 3 years and the warrant shall be locked up for the first 2 years whereas during the lock up period the warrant will not be able to be exercised.

https://www.stemcellsgroup.com/meso-numismatics-closes-global-stem-cell-group-acquisition/

The New York University Stern School of Business publishes P/E data for different industries, including the retail industry.

..The roster of firms includes large-cap stocks, such as Walmart (WMT), Costco Wholesale (COST), which trade on the major exchanges..But it also includes smaller stocks that trade over-the-counter,like..Meso Numismatics(MSSV).

https://www.investopedia.com/ask/answers/071615/what-average-pricetoearnings-ratio-retail-sector.asp




Companies

https://www.stemcellsgroup.com/companies/

Global Stem Cells Group Plans Bone Marrow Clinical Trials For Knee Osteoarthritis

..According to the Centers for Disease Control (CDC), knee osteoarthritis will affect 67 million people in the United States by 2030.

https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/

Estimated Primary Completion Date : March 15, 2022
https://clinicaltrials.gov/ct2/show/NCT03752827

Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/

Global Stem Cells Group Takes Part in Clinical Trials
Up to 20 centers in the United States have will be invited to enroll in the study.

..Faculty members from the Global Stem Cells Group will be treating subjects enrolled in the study. Global was chosen to participate in this study due to its unique stature as a leader in regenerative medicine. The group is known for its comprehensive support of regenerative medicine solutions, starting with education, patient treatment and research and ending with the manufacturing and distribution of equipment for regenerative medicine practitioners.

https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/

Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.

https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/

GLOBAL STEM CELLS GROUP TO LAUNCH FDA-REGISTERED SVF KITS

https://www.stemcellsgroup.com/fimestempiakit/

Global Stem Cells Group subsidiary Adimarket is preparing to launch Progenikine™, a new SVF closed system kit utilizing EmCyte technology, containing all the elements necessary to process adipose tissue and obtain stromal vascular fraction in a sterile environment

https://www.prweb.com/releases/globalstemcellsgroup/progenikine_kit/prweb13453468.htm


StemData is a complete cloud-based solution to simplify your Regenerative Medicine practice.

https://stemdata.org/

Labs



We specialize in delivering highly customized stem cell laboratory projects, providing our clients with cohesive and cost-efficient solutions.

https://stemcellslab.net/
https://stemcellslab.net/news/

GSCG News

https://www.stemcellsgroup.com/press-releases/

GSCG..EXPAND..permanent office in Cancun, Mexico

https://www.stemcellsgroup.com/the-groups-new-permanent-office-in-cancun-will-help-streamline-the-patient-experience-by-providing-holistic-support-throughout-the-treatment-process/

Bioscience Institute signed a landmark agreement with Miami-based Global Stem Cells Group..committed to promoting the widespread use of cell therapy treatments using mesenchymal stem cells (ADSCs) according to the know-how developed by the Bioscience Institute.


https://bioinst.com/en/bioscience-institute-announces-a-partnership-with-global-stem-cells-group/

North America Captured The Largest Market Share and is Expected to Retain its Dominance .. National Cancer Institute (NCI) had stated that the national expenditure on cancer care was expected to reach USD 156 billion by 2020..the current situation of COVID-19 is another factor driving the growth of the market

https://www.mordorintelligence.com/industry-reports/stem-cell-research-market

New Studies Show Mesenchymal Stem Cells Promising in Treatment of COVID-19..decades now– that Mesenchymal Stem Cells have the ability to target inflammation, regulate immune system function, and stimulate the recovery of cells.

https://www.stemcellsgroup.com/new-studies-show-mesenchymal-stem-cells-promising-in-treatment-of-covid-19/

ASCs are a promising cell source for regenerative medicine.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131273/


https://www.issca.us/

VITANOVAS Infusion Packages

Our Infusion Packages are delivered on-demand to homes, offices, or hotels, and administered by certified healthcare professionals. Our IV infusion packages are mixed with essential fluids, electrolytes, vitamins and antioxidants as a powerful cocktail to stimulate the immune system and help bolster it to assist in fighting infection. Immune modulation is the balancing and enhancing of cells in the body to work more effectively at fighting off disease, and it is one of the guiding principles behind our medical philosophy.

https://vitanovas.net/

GSCG and Adimarket to represent Megellan in Latina America and Middle East.





MSSV Supplier N-Biotek catalog 108 pages.

http://n-biotek.com/N-BIOTEK_PRODUCT_CATALOG_VOL_18.pdf

ADIMARKET
The Marketplace for Regenerative Medicine Doctors


GSCG and Adimarket to represent Megellan in Latina America and Middle East.
“We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,”

https://www.stemcellsgroup.com/adimarket-launches-website/
https://www.adimarket.net/

Cutting-Edge Online Training in Regenerative Medicine Learn from the Leaders in Regenerative Medicine Procedures.

https://www.stemcellscourse.com/

The Science & Clinical Applications

Exosomes are small membrane vesicles secreted by most cell types, Internal vesicles form by the inward budding of cellular compartments known as multivesicular endosomes (MVE). When MVE fuse with the plasma membrane, these internal vesicles are released as exosomes, which can travel to distant tissues to influence various aspects of cell behavior and physiology.
Does not contain DNA.
Does not contain Mitochondria.
Does not contain Golgi Apparatus
~1/1,000 the size of a cell.
Direct cell to cell communication

https://cellgenic.com/the-science/



Jan 10th, 2022

Stem Cell Center Opens Facility in Argentina, Bringing Advanced Health Technology ..Stem Cell Center is an international network of medical practices dedicated to bringing stem cell therapies to patients across the world.

https://www.digitaljournal.com/pr/stem-cell-center-opens-facility-in-argentina-bringing-advanced-health-technology

Harvard

..Our mission is to find cures for human diseases.

https://hsci.harvard.edu/

Any patient with any disease’ HARVARD

Sana Biotechnology licenses innovative immune-silent stem cell technology developed though Harvard’s Blavatnik Biomedical Accelerator

https://hsci.harvard.edu/news/any-patient-any-disease

Johns Hopkins

The most successful stem cell therapy—bone marrow transplant—has been around for more than 40 years. Johns Hopkins researchers played an integral role in establishing the methods for how bone marrow transplants are done

https://www.hopkinsmedicine.org/stem_cell_research/cell_therapy/index.html

Yale

The potential impact of stem cell research on human health is enormous.

https://medicine.yale.edu/stemcell/people/research/therapy.aspx
https://medicine.yale.edu/news/medicineatyale/a-shangrila-for-stem-cell-research-at-yale.aspx

OXFORD

a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon.

https://www.stemcells.ox.ac.uk/home

Stem cells could be the new antibiotics," says Joshua Hare, director of the Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine. "When you put the pieces of the puzzle together, stem cells could touch just about every area of medicine."

https://www.usnews.com/news/healthcare-of-tomorrow/articles/2017-10-04/stem-cells-may-hold-the-fix?context=amp

STEM CELLS CANCER TREATMENT..COST $350,000 to $800,000

https://amp.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/why-stem-cell-transplants-are-used.html

a corneal graft can restore sight in corneal blindness;

https://www.who.int/transplantation/cell_tissue/en/

..US health..spending increased 5.8%..$3.2 Trillion which is also expected to impel the growth of stem Cell and regenerative medicine market in the North America. U.S. is the prominent market driving the growth in the region.

https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html





.Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America.

https://www.stemcellsgroup.com/tag/3d-bioprinnting/

3D Bioprinting Market To Reach USD 4.40 Billion

https://www.globenewswire.com/news-release/2019/05/02/1815536/0/en/3D-Bioprinting-Market-To-Reach-USD-4-40-Billion-By-2026-Reports-And-Data.html

The blood stem cell Holy Grail?

https://www.ncbi.nlm.nih.gov/m/pubmed/20829472/

GSCG PRP and stem cell treatments being studied for hair loss

http://www.stemcellsgroup.com/prp-stem-cell-treatments-studied-hair-loss/

ADIMARKET.. launch..Cellgenic stem cell protein..hair restoration product

https://www.prunderground.com/adimarket-announces-launch-of-cellgenic-stem-cell-protein-extract-hair-restoration-product/00129425/

Hair Transplant Market worth over $24.8 billion

https://www.globenewswire.com/news-release/2018/08/14/1551331/0/en/Hair-Transplant-Market-worth-over-24-8-billion-by-2024-Global-Market-Insights-Inc.html

hair to cartilage, which, if successful could be a huge medical breakthrough. The startup has already reportedly reached a $12 billion valuation, much higher than most early-stage biotech companies.

https://www.businessinsider.com.au/samumed-ceo-on-valuation-2016-5

ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center Belgium’s Churchill Aesthetic Center

http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/



Cell Culture Media Market

The global cell culture media market can now envision a leap from USD 703.1 million to USD 1290.1 million during the forecast period (2017-2023).

https://www.marketwatch.com/press-release/cell-culture-media-market-2018-assessment-industry-forecast-highlighting-growth-trends-up-to-2023-2018-10-11

Pfizer recognizes the enormous potential of stem cell research.

https://www.pfizer.com/science/clinical-trials/integrity-and-transparency/stem-cell-research

Pfizer and Allergan Merge in $160 Billion Deal



https://bioinformant.com/pfizer-and-allergan-merge-in-160-billion-deal-to-become-new-behemoth-in-the-drug-world/amp/

Teva Bets on Stem Cells, Cancer in $6.2 Billion Cephalon Bid

https://www.bloomberg.com/news/articles/2011-05-02/teva-to-acquire-cephalon-for-81-50-per-share-in-cash

BrainStorm gets FDA okay for stem cell trial in MS patients
..The global MS drugs market is expected to exceed $27 billion by 2025 from $16 billion in 2016, according to Research and Markets.

https://www.reuters.com/article/us-brainstorm-cell-study/brainstorm-gets-fda-okay-for-stem-cell-trial-in-ms-patients-idUSKBN1OG1EX

..AbbVie Buying Cancer Drug Startup Stemcentrx for $10.2 Billion

https://fortune.com/2016/04/28/abbvie-stemcentx/

There are over 5,000 registered clinical trials involving stem cells research on ClinicalTrials.gov, with new clinical trials in this field being offered every day.

http://stemcellsportal.com/stem-cells-translational-medicine-clinical-trials-portal
https://clinicaltrials.gov/ct2/show/NCT03818737


https://www.nanalyze.com/2019/08/top-10-companies-longevity







We are now in the earliest stages of stem cell therapy development. Future therapies will be transformative and, frankly, mind-boggling.

https://www.inc.com/james-paine/3-industries-that-will-probably-create-the-first-trillionaire.html

competitor $1.99


Stem Cells market conservative measure.

1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Tourism $179 B
4 Organ repair $60B
5 Stem Bank $17.3B
6 3D printers $4B
7 Knee replacement?
8 Heart?
9 ?

All public info, invest wisely.

$MSSV GSCG Future of Medicine $5-$10-$15-$20$$?



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.